Plant-based wound dressing delivers antibiotics to prevent early infection

Researchers have developed a plant-based wound dressing capable of delivering antibiotics directly to wounds during the critical early stages of infection, offering a sustainable alternative to traditional medical treatments. The innovation, led by a team from the University of Bath, utilizes renewable furan-based polymers—previously explored for eco-friendly plastics and packaging—to create a two-sided dressing that combats bacterial biofilms, a major cause of delayed healing and treatment failure, according to a study published in *Bioactive Materials*.

The dressing’s design leverages the unique properties of plant-derived materials to address a global healthcare challenge: wound infections. Bacteria can form protective biofilms within hours of entering a wound, complicating treatment and increasing the risk of severe complications. The Bath team’s solution intervenes in this early window, releasing antibiotics such as tetracycline directly into the wound while maintaining a barrier to regulate moisture and prevent drug loss. Laboratory tests demonstrated that the dressing reduced biofilm formation by over 90% within four hours, significantly outperforming conventional dressings that often rely on petroleum-based plastics or chemical additives, as reported by the University of Bath.

Central to the technology is the use of two plant-based polymers with nearly identical chemical structures but distinct functional properties. By spinning these materials into ultra-fine fibres, the researchers amplified their molecular differences, enabling the dressing to act as both a targeted drug delivery system and a protective shield. Dr. Xiang Ding, the study’s lead author, emphasized that this approach eliminates the need for additional chemical modifications, streamlining production and enhancing biocompatibility. The material’s compatibility with human skin cells, confirmed through toxicity tests, further supports its potential for clinical use, as detailed in the *University of Bath* announcement.

While the Bath study focuses on synthetic polymers, other research highlights the broader role of natural plant compounds in wound care. A hydrogel developed by researchers using extracts from *Rhodomyrtus tomentosa* leaves and *Quercus infectoria* galls showed potent antibacterial activity against dual-species biofilms in ex vivo models, according to a study in *Nature Communications*. Similarly, AMERIGEL’s oak extract-based hydrogel, which utilizes tannins to inhibit bacterial growth and reduce inflammation, has been widely adopted in clinical settings, as noted on the AMERIGEL website. These examples underscore the growing interest in harnessing plant-derived bioactive agents to address antibiotic resistance and minimize side effects associated with synthetic treatments.

Electrospun nanofibers made from plant materials also represent a promising avenue. A review published in *PMC* highlights how electrospinning technology can produce nano-scale fibers with tailored properties, such as enhanced breathability, moisture retention, and controlled drug release. Natural products like cellulose, alginate, and plant proteins are increasingly being integrated into these structures, offering biodegradable, biocompatible alternatives to synthetic polymers. For instance, cellulose-based nanofibers infused with curcumin or witch hazel extract have shown improved wound healing outcomes in preclinical studies, while alginate-based dressings demonstrate strong antibacterial activity against pathogens like *Staphylococcus aureus* and *Pseudomonas aeruginosa*, as outlined in the *PMC* review.

The shift toward plant-based wound care reflects broader efforts to reduce environmental impact and improve patient outcomes. Traditional dressings often adhere to wounds during changes, causing pain and tissue damage, whereas plant-derived materials are designed to minimize such complications. Additionally, the use of renewable resources aligns with global sustainability goals, addressing the high costs and ecological footprint of conventional medical supplies. However, challenges remain, including scaling production, ensuring consistent quality, and navigating regulatory approvals for clinical trials, as noted in the *PMC* review.

Collaborative efforts between academia, industry, and healthcare providers are critical to advancing these innovations. The Bath team’s work, supported by the University of Bristol and Newcastle University, exemplifies the interdisciplinary approach needed to translate laboratory findings into practical solutions. As research continues, the integration of plant-based materials into wound care could redefine standards for infection prevention, offering a more sustainable and effective approach to a persistent medical challenge, as highlighted in the University of Bath’s announcement.